Country of Origin Regulations 2020 for Listed and Registered Medicines
Country of Origin Regulations 2020 for Listed and Registered Medicines [...]
New Permissible Ingredients Determination (No. 4) of 2019
The Permissible Ingredient Determination (No. 4 of 2019) has been published [...]
FSANZ Role in Food Regulation
Are you clear on what FSANZ's role is in food [...]
eBS Permitted Indications
Effective March 8th 2018 Permitted indications are now available through [...]
TGA eBS Outage
The Therapeutic Goods Amendment Bill No.1. of 2017 received royal [...]
Changes to the Uniform Recall Procedure for Therapeutic Goods
The Uniform Recall Procedure for Therapeutic Goods (URPTG) is a [...]
Consultation: Business Process Improvements Supporting Complementary Medicines Assessment Pathways
The TGA is seeking comments from interested parties on a [...]
Updated Permissible Ingredients Determination
An updated version of the Therapeutic Goods (Permissible Ingredients) Determination [...]
Pharmacovigilance Update
On 1st September 2017, the TGA published the revised edition [...]
Listed Medicine Reforms – Permitted Indications and Application Fees
Permitted Indications The closing date for proposing additional indications or [...]